Advertisement King Pharma completes sale of manufacturing facility - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

King Pharma completes sale of manufacturing facility

JHP Pharmaceuticals has acquired King Pharmaceuticals's Rochester, Michigan sterile manufacturing facility, some of the legacy products, and the related contract manufacturing business, for approximately $93 million in cash.

All current employees at the Rochester manufacturing facility have become JHP employees.

Peter Jenkins, CEO of JHP, said: “JHP is deeply appreciative of King’s support in the enormous amount of work that has been undertaken to ensure that the Rochester facility operates within the JHP corporate and technology platform from October 1.”